Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 29, 2013
Jun. 30, 2012
Cash flows from operating activities:    
Net income $ 21,365 $ 21,870
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,565 3,576
(Gain)Loss on disposal of assets 15 (21)
Gain on investment in business (528) 0
Unrealized foreign exchange gain 0 15
Provision for deferred income taxes (14) 1
Allowance for doubtful accounts (29) (15)
Stock-based compensation expense 1,416 1,157
(Increase) decrease in:    
Accounts receivable (6,740) (5,442)
Inventories 186 (890)
Income taxes receivable 728 120
Other current assets (677) (356)
Other assets 258 181
Increase (decrease) in:    
Accounts payable 864 403
Accrued expenses and other liabilities 1,617 2,834
Income taxes payable 1,430 342
Other noncurrent liabilities (1) 25
Net cash provided by operating activities 23,455 23,800
Cash flows from investing activities:    
Investment in business, net of cash acquired (923) 0
Capital expenditures (9,518) (4,752)
Proceeds from dispositions of equipment 0 21
Purchases of short-term investments (11,888) (12,251)
Proceeds from sale of short-term investments 11,744 3,130
Net cash used in investing activities (10,585) (13,852)
Cash flows from financing activities:    
Proceeds from stock issued 466 333
Dividends to shareholders (4,710) (7,769)
Change in restricted cash 21 2
Net cash used in financing activities (4,223) (7,434)
Effect of exchange rate changes on cash and cash equivalents (1,439) (311)
Net increase (decrease) in cash and cash equivalents 7,208 2,203
Cash and cash equivalents, beginning of period 34,478 51,262
Cash and cash equivalents, end of period 41,686 53,465
Cash paid:    
Income taxes 8,161 10,272
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities 3,486 4,407
Common stock issued for deferred director’s compensation through other noncurrent liabilities $ 294 $ 930